2024/03/28 08:00:48 | |
---|---|
Price | |
361.40 EUR | |
Difference | 1.46% (5.20) |
ISIN | US9553061055 |
Symbol | WST |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 26,845 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 361.40 EUR |
High | 361.40 EUR |
Low | 361.40 EUR |
Close (prev. day) | 356.20 EUR |
VWAP | 369.90 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | - |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 08:00:48 | |
---|---|
Price | |
361.40 EUR | |
Difference | 1.46% (5.20) |
ISIN | US9553061055 |
Symbol | WST |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 26,845 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 361.40 EUR |
High | 361.40 EUR |
Low | 361.40 EUR |
Close (prev. day) | 356.20 EUR |
VWAP | 369.90 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +1.95% | +17.05% | +55.78% |
Perf (abs.) | +6.90 | +52.65 | +129.40 |
Beta | 1.41 | 1.08 | 1.09 |
Volatility | 38.46 | 32.46 | 34.27 |
Ø price 5 days | Ø volume 5 days (pcs.) | 359.42 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 340.72 EUR (6) |
Ø price 100 days | Ø volume 100 days (pcs.) | 329.94 EUR (3) |
Ø price 250 days | Ø volume 250 days (pcs.) | 335.94 EUR (3) |
YTD High | date | 380.10 EUR (2024/02/08) |
YTD Low | date | 307.30 EUR (2024/01/04) |
52 Weeks High | date | 380.10 EUR (2024/02/08) |
52 Weeks Low | date | 298.90 EUR (2023/10/31) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2023/10/25 | 17:35 | 342.50 EUR | 0.00 | 2 |
Tradegate | 2024/03/28 | 22:26 | 366.70 EUR | 0.00 | 2 |
Stuttgart | 2024/03/28 | 08:02 | 360.50 EUR | 0.00 | 3 |
NYSE | 2024/03/28 | 21:00 | 395.71 USD | 93.60 | 8,242 |
Munich | 2024/03/28 | 08:05 | 362.70 EUR | 0.00 | 1 |
Hanover | 2024/03/28 | 08:11 | 361.40 EUR | 0.00 | 1 |
Frankfurt | 2024/03/28 | 08:00 | 361.40 EUR | 0.00 | 2 |
Duesseldorf | 2024/03/28 | 19:30 | 366.00 EUR | 0.00 | 7 |
Berlin | 2024/03/28 | 08:13 | 362.80 EUR | 0.00 | 2 |
BX Swiss | 2023/07/11 | 18:00 | 334.805 CHF | 0.00 | 1 |
WEST PHARMACEUTICAL SERVICES INC. |
- - |
PO Box 645, Gordon Drive 101 19341-0645 Lionville, PA |
Telefon: +1 610 594 3319 |
Fax: +1 610 594 3000 |
E-mail: Mike.Anderson@westpharma.com |
- |
Myla Lai-Goldman | Member of Board of Directors |
Stephen Lockhart | Member of Board of Directors |
William Feehery | Member of Board of Directors |
Deborah Keller | Member of Board of Directors |
Douglas Michels | Member of Board of Directors |
Mark Buthman | Member of Board of Directors |
Molly Joseph | Member of Board of Directors |
Paolo Pucci | Member of Board of Directors |
Robert Friel | Member of Board of Directors |
Thomas Hofmann | Member of Board of Directors |
Eric M. Green | Chairman of Managing Board |
Quintin Lai | Member of Executive Committee |
Andy Polywacz | Member of Executive Committee |
Annette F. Favorite | Member of Executive Committee |
Bernard J. Birkett | Member of Executive Committee |
Chris Ryan | Member of Executive Committee |
Cindy Reiss-Clark | Member of Executive Committee |
David A. Montecalvo | Member of Executive Committee |
Kimberly Banks MacKay | Member of Executive Committee |
Silji Abraham | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer